Healthcare+ Expo 台灣醫療科技展

台灣醫療科技展 完美閉幕 明年見～

世延生醫年度回顧與展望 聚焦海外行銷與新技術布局

世延生醫今年在醫材取證上取得重大進展，為未來海外市場拓展奠定基礎。展望 2026 年，公司將以海外行銷為重點，預計參加 3 月廣州華南口腔展、9 月新加坡 MEDICA 展、11 月德國 MEDICA 展，更多行程也正在規劃中，敬請期待。

世延生醫邁入第十年，正實踐「十年磨一劍」的承諾：除了在東南亞持續取證、歐洲進行人種驗證及推動口腔癌檢測試劑海外行銷外，血液胞泌體檢測套組、磁電化學檢測技術等新產品亦將成為下一波臨床應用焦點。

S&T BioMed Reviews 2025 Achievements and Looks Ahead to Global Expansion

S&T BioMed made significant regulatory progress this year, laying a solid foundation for its international market expansion. In 2026, the company will focus on overseas marketing, with planned participation in the South China Dental Show in Guangzhou (March), Singapore MEDICA (September), and Germany MEDICA (November), with more events to be announced.

Marking its 10th anniversary, S&T BioMed is truly realizing its “ten years of honing a sword” commitment. In addition to continuing regulatory approvals in Southeast Asia, conducting population validation in Europe, and promoting oral cancer diagnostic kits abroad, the company’s emerging products and technologies—including blood exosome assays and magneto-electrochemical detection platforms—will represent the next wave of clinical applications.